MedPath

A non-randomized confirmatory trial of minimum invasive laparoscopic radical hysterectomy (new-Japanese LRH) for patients with early-stage cervical cancer

Not Applicable
Recruiting
Conditions
cervical cancer
Registration Number
JPRN-UMIN000045224
Lead Sponsor
Kobe university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
440
Inclusion Criteria

Not provided

Exclusion Criteria

1.Tumor diameter of cervical cancer exceeding 4cm(Patients will not be eligible for this study if the tumor diameter exceeds 4 cm in any one of the following: measurement by MRI, direct measurement by colposcopy, or measurement by conization specimen) 2.Active multiple cancers (concurrent multiple cancers and heterogeneous multiple cancers with disease-free interval of 5 years or less). However, carcinoma in situ (intraepithelial carcinoma) and intramucosal carcinoma equivalent lesions that are considered curable by local treatment are not included in active multiple cancers). 3.History of radiotherapy treatment to the abdomen or pelvis. 4.Active infection. 5.Fever of 38 degree or higher at the time of registration. 6.Pregnant or breastfeeding. 7.Psychiatric illness/symptoms that would limit compliance the study requirement. 8.Receiving continuous systemic administration of steroids (oral or intravenous). 9.Uncontrolled diabetes mellitus or diabetes mellitus by continuous insulin use. 10.Uncontrolled hypertension

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath